Long-term renoprotective effect of SGLT2 inhibitors

Long-term renoprotective effect of SGLT2 inhibitors - Renoprotection by SGLT2 inhibitors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034387

Enrollment

Registered

2018-11-01

Start date

2018-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes melllitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The cases receiving SGLT2 inhibitors for 3 years or loger at JA Toride Medical Center

Exclusion criteria

Exclusion criteria: nothing particular

Design outcomes

Primary

Measure	Time frame
decline rate of eGFR three years before and afater administration of SGLT2 inhibitors	—

Secondary

Measure	Time frame
clinical factors affecting decline rate of eGFR before and afater administration of SGLT2 inhibitors quantitative changes of albuminuria and proteinuria	—

Countries

Japan

Contacts

Public ContactYoshitaka Maeda

JA Toride Medical Center Nephrology

yoshimaeda43@toride-medical.or.jp81-297-74-5551

Outcome results